Dr. Reid Leonard brings with him a wide array of experience in company formation, drug discovery, business development, and venture capital, having participated in the start-up of several other venture-backed companies: Potenza Therapeutics, Tizona Therapeutics, Trieza Therapeutics, and Twentyeight-Seven, Inc.
Dr. Leonard began his career with Merck & Co., where he served the company for over 25 years. Initially, he carried out discovery research on ion-channel and GPCR targets before moving into business development and licensing. In his later years at Merck, he was instrumental in the formation of the Merck Research Labs Venture Fund. Dr. Leonard retired from Merck as Managing Director of MRL Ventures and Executive Director in Business Development.
Dr. Leonard graduated from Brandeis University with an A.B. in Biology and Psychology, holds a Ph.D. in Biology from Purdue University, and completed a postdoctoral fellowship in molecular pharmacology at Caltech with Profs. Henry Lester and Norman Davidson.
How do I contact Reid Leonard?
Has Reid Leonard been buying or selling shares of Werewolf Therapeutics?
Reid Leonard has not been actively trading shares of Werewolf Therapeutics over the course of the past ninety days. Most recently, Reid Leonard sold 3,000 shares of the business's stock in a transaction on Wednesday, December 15th. The shares were sold at an average price of $13.41, for a transaction totalling $40,230.00. Learn More on Reid Leonard's trading history.
Are insiders buying or selling shares of Werewolf Therapeutics?
In the last twelve months, Werewolf Therapeutics insiders bought shares 2 times. They purchased a total of 483,452 shares worth more than $435,273.40. In the last twelve months, insiders at the sold shares 86 times. They sold a total of 5,115,088 shares worth more than $5,878,252.60. The most recent insider tranaction occured on December, 4th when Director Luke Evnin sold 53,416 shares worth more than $51,813.52. Insiders at Werewolf Therapeutics own 23.6% of the company.
Learn More about insider trades at Werewolf Therapeutics. Information on this page was last updated on 12/4/2025.
